Cargando…

Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt‐related pulmonary arterial hypertension

AIMS: Orchestrating the transition from reversible medial hypertrophy to irreversible plexiform lesions is crucial for pulmonary arterial hypertension related to congenital heart disease (CHD‐PAH). Transgelin is an actin‐binding protein that modulates pulmonary arterial smooth muscle cell (PASMC) dy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jing‐jing, Yang, Jian, Li, Li, Quan, Rui‐lin, Chen, Xiao‐xi, Qian, Yu‐ling, Huang, Li, Wang, Pei‐he, Li, Yue, Meng, Xian‐min, Chen, Xi, Gu, Qing, He, Jian‐Guo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715770/ https://www.ncbi.nlm.nih.gov/pubmed/35841124 http://dx.doi.org/10.1002/ehf2.14080

Ejemplares similares

Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
por: Huang, Li, et al.
Publicado: (2018)

Synemin promotes pulmonary artery smooth muscle cell phenotypic switch in shunt‐induced pulmonary arterial hypertension
por: Zhou, Jingjing
Publicado: (2022)

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
por: Chen, Yong-Jie, et al.
Publicado: (2021)

Effect of EZH2 on pulmonary artery smooth muscle cell migration in pulmonary hypertension
por: Wang, Ying, et al.
Publicado: (2021)

The Role and Regulation of Pulmonary Artery Smooth Muscle Cells in Pulmonary Hypertension
por: He, Shixin, et al.
Publicado: (2020)

The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension
por: Zeng, Wei-Jie, et al.
Publicado: (2012)

Vital Roles of Gremlin‐1 in Pulmonary Arterial Hypertension Induced by Systemic‐to‐Pulmonary Shunts
por: Meng, Liukun, et al.
Publicado: (2020)

Mitochondrial dysfunction in pulmonary arterial hypertension
por: Zhang, Weiwei, et al.
Publicado: (2022)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

Differences in disease severity and prognosis of exercise-induced right-to-left shunt between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients
por: Wang, Shang, et al.
Publicado: (2022)

Contemporary survival of patients with pulmonary arterial hypertension and congenital systemic to pulmonary shunts
por: Vijarnsorn, Chodchanok, et al.
Publicado: (2018)

Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system
por: Liu, Chen, et al.
Publicado: (2016)

Astragaloside IV restrains pyroptosis and fibrotic development of pulmonary artery smooth muscle cells to ameliorate pulmonary artery hypertension through the PHD2/HIF1α signaling pathway
por: Xi, Jie, et al.
Publicado: (2023)

Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells
por: Liu, Ping, et al.
Publicado: (2021)

Endogenous Estrogen Attenuates Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Vasoconstriction and Pulmonary Arterial Smooth Muscle Cells Proliferation
por: Xu, Dunquan, et al.
Publicado: (2013)

Zinc-mediated activation of CREB pathway in proliferation of pulmonary artery smooth muscle cells in pulmonary hypertension
por: Xiao, Genfa, et al.
Publicado: (2021)

Pulmonary artery dysfunction in chronic thromboembolic pulmonary hypertension
por: Chibana, Hidetoshi, et al.
Publicado: (2017)

Alteration of Extracellular Superoxide Dismutase in Idiopathic Pulmonary Arterial Hypertension
por: Zhang, Rui, et al.
Publicado: (2020)

Purinergic Dysfunction in Pulmonary Arterial Hypertension
por: Cai, Zongye, et al.
Publicado: (2020)

Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells
por: Gao, Lan, et al.
Publicado: (2017)

Postpartum pulmonary circulation in pregnant rats with monocrotaline-induced pulmonary arterial hypertension
por: Jing, He, et al.
Publicado: (2020)

Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension
por: Xu, Dan, et al.
Publicado: (2022)

Intracellular iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension in mice
por: Lakhal-Littleton, Samira, et al.
Publicado: (2019)

CTRP9 Mitigates the Progression of Arteriovenous Shunt-Induced Pulmonary Artery Hypertension in Rats
por: Guan, Hua, et al.
Publicado: (2021)

Bile acid predicts congenital portosystemic venous shunt in patients with pulmonary arterial hypertension
por: Li, Yunyan, et al.
Publicado: (2023)

Transcatheter Valve Implantation in Reversed Potts Shunt in Pulmonary Arterial Hypertension: Keeping the Shunt Reversed
por: Goldar, Ghazaleh, et al.
Publicado: (2022)

Hypoxia induces pulmonary artery smooth muscle dysfunction through mitochondrial fragmentation-mediated endoplasmic reticulum stress
por: Zhuan, Bing, et al.
Publicado: (2020)

Proteomic analysis of pulmonary arterial hypertension
por: Qin, Xiaohan, et al.
Publicado: (2021)

Characteristics of Pulmonary Vascular Remodeling in a Novel Model of Shunt-Associated Pulmonary Arterial Hypertension
por: Zhang, Mingjie, et al.
Publicado: (2018)

Deglycosylated Azithromycin Targets Transgelin to Enhance Intestinal Smooth Muscle Function
por: Zhong, Weilong, et al.
Publicado: (2020)

Pulmonary arterial hypertension caused by congenital extrahepatic portocaval shunt: a case report
por: Lin, Kai-yang, et al.
Publicado: (2019)

Pharmacological Alteration of Cellular Mechanical Properties in Pulmonary Arterial Smooth Muscle Cells of Idiopathic Pulmonary Arterial Hypertension
por: Katsuragi, Shinichi, et al.
Publicado: (2021)

Ubiquitinated AIF is a major mediator of hypoxia-induced mitochondrial dysfunction and pulmonary artery smooth muscle cell proliferation
por: Ma, Cui, et al.
Publicado: (2022)

Regulation of Pulmonary Vascular Smooth Muscle Contractility in Pulmonary Arterial Hypertension: Implications for Therapy
por: Lyle, Melissa A., et al.
Publicado: (2017)

Role of macrophages in pulmonary arterial hypertension
por: Zhang, Meng-Qi, et al.
Publicado: (2023)

Kidney dysfunction in patients with pulmonary arterial hypertension
por: Nickel, N.P., et al.
Publicado: (2017)

A Case of Pulmonary Arterial Hypertension Associated with Congenital Extrahepatic Portocaval Shunt
por: Yi, Jeong-Eun, et al.
Publicado: (2014)

Pulmonary Arterial Hypertension in a Patient with a Portosystemic Shunt: Diagnostic Challenge
por: Stepffer, Carolina, et al.
Publicado: (2020)

Potts shunt as an effective palliation for patients with end stage pulmonary arterial hypertension
por: Bobhate, Prashant, et al.
Publicado: (2021)

Incorporation of noninvasive assessments in risk prediction for pulmonary arterial hypertension
por: Quan, Ruilin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_29j8n1a7b9k0ag8vbqfb5f2cg5